LCM
AGN

LionEye Capital Management’s Allergan plc AGN Stock Holding History

LionEye Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-74,000
Closed -$9.34M – 74
2013
Q2 		$9.34M Buy
+74,000
New +$8.38M 2.61% 14

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

LionEye Capital Management's AGN Position: Q3 2013 in Review

LionEye Capital Management sold out of Allergan plc (AGN) in Q3 2013, closing a stake of 74,000 shares — an estimated $9.34M sold.

LionEye Capital Management first reported a position in AGN in Q2 2013 and held it in 1 quarter. The position peaked at $9.34M in Q2 2013. 479 funds tracked by Wall St. Rank hold AGN as of Q3 2013.

  • LionEye Capital Management reported no remaining Allergan plc position as of Q3 2013 after selling out during the quarter.
  • LionEye Capital Management sold 74,000 Allergan plc shares in Q3 2013, an estimated $9.34M.
  • LionEye Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 1 quarter.
  • LionEye Capital Management's Allergan plc position peaked at $9.34M in Q2 2013.
  • 479 funds tracked by Wall St. Rank held Allergan plc as of Q3 2013.

Based on LionEye Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.